Literature DB >> 19861335

Enhancing antibiotic activity: a strategy to control Acinetobacter infections.

Sasitorn Chusri1, Ivan Villanueva, Supayang Piyawan Voravuthikunchai, Julian Davies.   

Abstract

OBJECTIVES: The emergence of antibiotic resistance has seriously diminished antibiotic efficacy and an increasing number of infections are becoming difficult to treat. One approach to the restoration of antibiotic activity is to administer them in conjunction with non-antibiotic compounds that depress resistance mechanisms. We describe the activity of ellagic and tannic acids as adjuvants that enhance the activity of aminocoumarin antibiotics against multidrug-resistant (MDR) Acinetobacter baumannii.
METHODS: Adjuvant activity of plant phenolics was tested using growth inhibition assays in combination with subinhibitory concentrations of novobiocin. The antibacterial susceptibilities of susceptible and MDR A. baumannii to a variety of antibiotics were determined in the absence and presence of ellagic and tannic acids. The effect of the adjuvants on bacterial outer membrane function was examined by using the fluorescence dye 1-N-phenylnaphthylamine (NPN). The efflux pump inhibition was measured by the intracellular accumulation of ethidium bromide (EtBr) and pyronin Y.
RESULTS: At 40 microM, ellagic and tannic acids enhanced the activity of novobiocin, coumermycin, chlorobiocin, rifampicin and fusidic acid against A. baumannii. There were no increases in the uptake of NPN or in the accumulation of EtBr after strains were treated with these adjuvants; however, the intracellular accumulation of pyronin Y by the treated cells was significantly increased, suggesting that ellagic and tannic acids act as efflux pump inhibitors.
CONCLUSIONS: Susceptibility of MDR A. baumannii to a variety of antibiotics was enhanced in the presence of ellagic and tannic acids. The use of such plant compounds might provide effective treatments for resistant Gram-negative bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861335     DOI: 10.1093/jac/dkp381

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

1.  Discovery of antibiotic adjuvants.

Authors:  Maya A Farha; Eric D Brown
Journal:  Nat Biotechnol       Date:  2013-02       Impact factor: 54.908

2.  Terminalia chebula Retz. Fruit Extracts Inhibit Bacterial Triggers of Some Autoimmune Diseases and Potentiate the Activity of Tetracycline.

Authors:  Aaron Mandeville; Ian Edwin Cock
Journal:  Indian J Microbiol       Date:  2018-07-12       Impact factor: 2.461

Review 3.  Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance.

Authors:  Adam C Palmer; Roy Kishony
Journal:  Nat Rev Genet       Date:  2013-02-19       Impact factor: 53.242

4.  Synergistic effects of pomegranate and rosemary extracts in combination with antibiotics against antibiotic resistance and biofilm formation of Pseudomonas aeruginosa.

Authors:  Wael Mohamed Abu El-Wafa; Rahma Hassanein Ahmed; Mohamed Abdel-Halim Ramadan
Journal:  Braz J Microbiol       Date:  2020-05-12       Impact factor: 2.476

5.  Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infections.

Authors:  Pinanong Na Phatthalung; Sasitorn Chusri; Supayang P Voravuthikunchai
Journal:  BMC Complement Altern Med       Date:  2012-04-26       Impact factor: 3.659

6.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

Authors:  Michael Wink; Mohamed L Ashour; Mahmoud Zaki El-Readi
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

Review 7.  Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens.

Authors:  Vishvanath Tiwari; Ranita Roy; Monalisa Tiwari
Journal:  Front Microbiol       Date:  2015-06-18       Impact factor: 5.640

8.  Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.

Authors:  Premkumar Jayaraman; Kishore R Sakharkar; ChuSing Lim; Mohammad Imran Siddiqi; Sarinder K Dhillon; Meena K Sakharkar
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162

9.  Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumannii.

Authors:  Yoko Miyasaki; John D Rabenstein; Joshua Rhea; Marie-Laure Crouch; Ulla M Mocek; Patricia Emmett Kittell; Margie A Morgan; Wesley Stephen Nichols; M M Van Benschoten; William David Hardy; George Y Liu
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

10.  Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.

Authors:  Christina Kourtesi; Anthony R Ball; Ying-Ying Huang; Sanjay M Jachak; D Mariano A Vera; Proma Khondkar; Simon Gibbons; Michael R Hamblin; George P Tegos
Journal:  Open Microbiol J       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.